Prime Capital Investment Advisors LLC lifted its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 21.5% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 49,136 shares of the pharmacy operator’s stock after buying an additional 8,693 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Walgreens Boots Alliance were worth $2,718,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently bought and sold shares of WBA. Thomasville National Bank raised its stake in Walgreens Boots Alliance by 40.3% during the 2nd quarter. Thomasville National Bank now owns 4,475 shares of the pharmacy operator’s stock valued at $245,000 after purchasing an additional 1,285 shares during the period. Fulton Bank N.A. grew its holdings in Walgreens Boots Alliance by 23.7% during the 2nd quarter. Fulton Bank N.A. now owns 17,618 shares of the pharmacy operator’s stock valued at $963,000 after buying an additional 3,373 shares in the last quarter. Silverleafe Capital Partners LLC purchased a new position in Walgreens Boots Alliance during the 2nd quarter valued at approximately $459,000. Montecito Bank & Trust grew its holdings in Walgreens Boots Alliance by 7.8% during the 2nd quarter. Montecito Bank & Trust now owns 13,570 shares of the pharmacy operator’s stock valued at $742,000 after buying an additional 985 shares in the last quarter. Finally, WINTON GROUP Ltd grew its holdings in Walgreens Boots Alliance by 559.9% during the 2nd quarter. WINTON GROUP Ltd now owns 447,385 shares of the pharmacy operator’s stock valued at $24,459,000 after buying an additional 379,591 shares in the last quarter. 60.60% of the stock is currently owned by hedge funds and other institutional investors.
Several equities analysts have weighed in on the company. ValuEngine upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, October 30th. JPMorgan Chase & Co. cut Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and cut their price target for the company from $73.00 to $63.00 in a report on Wednesday, October 23rd. Deutsche Bank assumed coverage on Walgreens Boots Alliance in a report on Thursday, September 12th. They set a “sell” rating for the company. Cleveland Research restated a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 9th. Finally, Royal Bank of Canada cut Walgreens Boots Alliance to a “hold” rating and set a $59.00 price target for the company. in a report on Friday, September 27th. Five investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $61.35.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Monday, October 28th. The pharmacy operator reported $1.43 EPS for the quarter, topping the Zacks’ consensus estimate of $1.41 by $0.02. The firm had revenue of $33.95 billion during the quarter, compared to analysts’ expectations of $33.88 billion. Walgreens Boots Alliance had a return on equity of 21.99% and a net margin of 2.91%. The company’s quarterly revenue was up 1.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.48 EPS. As a group, analysts anticipate that Walgreens Boots Alliance Inc will post 5.93 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a $0.458 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 2.96%. The ex-dividend date of this dividend is Friday, November 15th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 30.55%.
In other news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the completion of the transaction, the chief accounting officer now owns 357,851 shares in the company, valued at approximately $18,064,318.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 15.73% of the stock is currently owned by insiders.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Understanding debt-to-equity ratio in fundamental analysis
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.